Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoid or delay treatment like surgery or radiation therapy and their life-changing complications.
Dana-Farber CEO on Mass General split: Boston needed a dedicated cancer hospital
One of the first items on Laurie Glimcher’s agenda after becoming CEO of the renowned Dana-Farber Cancer Institute was to build a freestanding cancer hospital
October 10, 2023